Reduction in morning blood pressure is a key factor for ameliorating urinary albumin excretion in patients with morning hypertension irrespective of treatment regimen

Circulation Journal

Volumn 77, Issue 6, 2013, Pages 1551-1557

  Kai, Hisashi ^a   Kaneyuki, Masashi ^a,d   Shihara, Miwako ^a,d   Toyama, Yasuyuki ^a,e   Mitsutake, Yoshiaki ^a,b   Umei, Hidekazu ^a,f   Kusaba, Ken ^a,g   Ueda, Tamenobu ^a   Adachi, Hisashi ^a,c   Imaizumi, Tsutomu ^a,h  

^a Department of Medicine Division of Cardiovascular Medicine   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Tanushimaru Central Hospital   (Japan)

^d Yokokura Hospital   (Japan)

^e Omuta City General Hospital   (Japan)

^f Toyama Hospital   (Japan)

^g Chikugo City Hospital   (Japan)

^h Yame General Hospital   (Japan)

Author keywords

Albuminuria; Angiotensin II receptor blocker; Diuretics; Home blood pressure measurement; Morning hypertension

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LOSARTAN;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHEMICAL ANALYSIS; CLINICAL EVALUATION; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALBUMINURIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MIDDLE AGED; TIME FACTORS;

EID: 84878261872     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1102     Document Type: Article

References (20)

1. Ueda T, Kai H, Imaizumi T, on behalf of the MAPPY Study Investigators. Losartan/hydrochlorothiazide combination vs. high dose losar-tan in patients with morning hypertension: A prospective, randomized, open-labeled, parallel-group, multicenter trial. Hypertens Res 2012; 35: 708-714.
2. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
3. Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician 2004; 33: 565-567.
4. Muller JE, Tofer GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79: 733-743.
5. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning hypertension: The strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006; 29: 581-587.
6. Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, et al. Prediction of stroke by home "morning" versus "evening" blood pressure values: The Ohasama study. Hypertension 2006; 48: 737-743.
7. Kario K, White WB. Early morning hypertension: What does it contribute to overall cardiovascular risk assessment? J Am Soc Hyper-tens 2008; 2: 397-402.
8. Kario K. Orthostatic hypertension: A measure of blood pressure variation for predicting cardiovascular risk. Circ J 2009; 73: 1002-1007.
9. Obara T, Ito K, Ohkubo T, Shibamiya T, Shinki T, Nakashita M, et al. Uncontrolled hypertension based on morning and evening home blood pressure measurements from the J-HOME study. Hypertens Res 2009; 32: 1072-1078.
10. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. Self-measured systolic blood pressure in the morning is a strong indicator of decline of renal function in hypertensive patients with non-diabetic chronic renal insuffciency. Clin Exp Hypertens 2002; 24: 249-260.
11. Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Clin Exp Hypertens 2005; 27: 129-138.
12. MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS. Losar-tan and low-dose hydrochlorothiazide in patients with essential hypertension: A double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996; 156: 278-285.
13. Fogari R, Derosa G, Zoppi A, Preti P, Lazzari P, Destro M, et al. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with micro-albuminuria. Am J Hypertens 2007; 20: 417-422.
14. Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, et al. Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? Circ J 2012; 76: 1415-1422.
15. Kamoi K, Ito T, Miyakoshi M, Minagawa S. Usefulness of home blood pressure measurement in the morning in patients with type 2 diabetes: Long-term results of a prospective longitudinal study. Clin Exp Hypertens 2010; 32: 184-192.
16. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol 2006; 17: 2106-2111.
17. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
18. Grimm RH Jr, Svendsen KH, Kasiske B, Keane WF, Wahi MM. Proteinuria is a risk factor for mortality over 10 years of follow-up: MRFIT Research Group: Multiple Risk Factor Intervention Trial. Kidney Int 1997; 63: S10-S14.
19. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, et al. Molecular identifcation of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417: 447-452.
20. Miyauchi K, Yamazaki T, Watada H, Tanaka Y, Kawamori R, Imai Y, et al. Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker in type 2 diabetes. Circ J 2012; 76: 2159-2166.